Healthcare Stakeholder Perspectives on a Value Assessment Approach for Duchenne Muscular Dystrophy Therapies
Ryan Fischer, Pat Furlong, Annie Kennedy, Kelly Maynard, Marissa Penrod, Debra Miller, View ORCID ProfileChamindra G. Laverty, View ORCID ProfileLinda Lowes, View ORCID ProfileNancy L. Kuntz, View ORCID ProfilePerry B. Shieh, Jane Kondejewski, Peter J. Neumann, View ORCID ProfileJason Shafrin, View ORCID ProfileRichard J. Willke
doi: https://doi.org/10.1101/2023.07.11.23292507
Ryan Fischer
aParent Project Muscular Dystrophy, Washington, DC;
Pat Furlong
aParent Project Muscular Dystrophy, Washington, DC;
Annie Kennedy
bEveryLife Foundation for Rare Diseases, Washington DC;
Kelly Maynard
cLittle Hercules Foundation, Dublin, OH;
dDuchenne Family Assistance Program;
Marissa Penrod
dDuchenne Family Assistance Program;
eTeam Joseph, West Bloomfield, MI;
Debra Miller
fCureDuchenne, Newport Beach, CA;
Chamindra G. Laverty
gUC San Diego, San Diego, CA;
MDLinda Lowes
hNationwide Children’s Hospital, Columbus, OH;
PhDNancy L. Kuntz
iNorthwestern University Feinberg School of Medicine, Chicago, IL;
MDPerry B. Shieh
jUCLA, Los Angeles, CA;
MD, PhDJane Kondejewski
kSNELL Medical Communication, Inc., Montreal, QC;
PhDPeter J. Neumann
lCenter for Evaluation of Value and Risk in Medicine, Boston, MA;
ScDJason Shafrin
mFTI Consulting, Los Angeles, CA;
PhDRichard J. Willke
nInternational Society for Pharmacoeconomics and Outcomes Research, Lawrenceville, NJ
PhDData Availability
Data sharing is not applicable to this article as no datasets were generated or analyzed during this study.
Posted July 12, 2023.
Healthcare Stakeholder Perspectives on a Value Assessment Approach for Duchenne Muscular Dystrophy Therapies
Ryan Fischer, Pat Furlong, Annie Kennedy, Kelly Maynard, Marissa Penrod, Debra Miller, Chamindra G. Laverty, Linda Lowes, Nancy L. Kuntz, Perry B. Shieh, Jane Kondejewski, Peter J. Neumann, Jason Shafrin, Richard J. Willke
medRxiv 2023.07.11.23292507; doi: https://doi.org/10.1101/2023.07.11.23292507
Healthcare Stakeholder Perspectives on a Value Assessment Approach for Duchenne Muscular Dystrophy Therapies
Ryan Fischer, Pat Furlong, Annie Kennedy, Kelly Maynard, Marissa Penrod, Debra Miller, Chamindra G. Laverty, Linda Lowes, Nancy L. Kuntz, Perry B. Shieh, Jane Kondejewski, Peter J. Neumann, Jason Shafrin, Richard J. Willke
medRxiv 2023.07.11.23292507; doi: https://doi.org/10.1101/2023.07.11.23292507
Subject Area
Subject Areas
- Addiction Medicine (398)
- Allergy and Immunology (708)
- Anesthesia (200)
- Cardiovascular Medicine (2911)
- Dermatology (249)
- Emergency Medicine (438)
- Epidemiology (12687)
- Forensic Medicine (10)
- Gastroenterology (825)
- Genetic and Genomic Medicine (4548)
- Geriatric Medicine (413)
- Health Economics (723)
- Health Informatics (2901)
- Health Policy (1067)
- Hematology (383)
- HIV/AIDS (920)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4313)
- Nursing (233)
- Nutrition (634)
- Oncology (2253)
- Ophthalmology (642)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (277)
- Palliative Medicine (83)
- Pathology (496)
- Pediatrics (1193)
- Primary Care Research (492)
- Public and Global Health (6901)
- Radiology and Imaging (1520)
- Respiratory Medicine (913)
- Rheumatology (435)
- Sports Medicine (381)
- Surgery (483)
- Toxicology (60)
- Transplantation (209)
- Urology (178)